OncLive® and Targeted Oncology™ Partner with the Association of Community Cancer Centers

OncLive® continues to expand Strategic Alliance Partnership program

CRANBURY, N.J.--()--OncLive® and Targeted Oncology™ are proud to announce they’ve partnered with the Association of Community Cancer Centers (ACCC) as a part of its Strategic Alliance Partnership (SAP) program, announced Michael J. Hennessy Jr., president of Michael J. Hennessy Associates, parent company of OncLive® and Targeted Oncology™.

In making the announcement, Michael J. Hennessy Jr. said, “It’s an honor to join hands with ACCC, a leader in advancing quality cancer care by providing how-to resources for the multidisciplinary care team and advocating for patient access to care. With this partnership, we hope to connect providers with real-world educational content that supports optimal care for patients with cancer.”

“ACCC content engages the entire community of cancer care professionals,” said Christian G. Downs, JD, MHA. “We look forward to partnering with OncLive® to expand the reach of strategies, solutions, and peer-to-peer insight on meeting the challenges faced by those on the frontlines of cancer care today.”

OncLive® and Targeted Oncology™ readers will benefit from this collaboration with ACCC by gaining access to actionable content, such as articles and interviews on effective practices that can help every member of the multidisciplinary cancer care team better serve patients. This provider-driven content will focus on ACCC programs including immuno-oncology (through the Institute for Clinical Immuno-Oncology (ICLIO), financial advocacy, pharmacy education, care coordination, and more.

The SAP program is designed to share medical innovations in an open exchange of information among trusted peers with the goal of better serving patients with care. SAP topics will range from best practices relative to practice-management strategies, on-boarding of new treatments, treatment decisions and much more.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can utilize to help provide the best patient care. OncLive.com is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management® and more. Michael J. Hennessy Associates, Inc. is a full-service health care communications company offering education, research, medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups. For more information, please visit: www.onclive.com.

About Targeted Oncology™

TargetedOnc.com provides the latest news and insight focused on next generation therapeutics and their molecular targets for practicing oncologists. As the field of oncology continues to trend toward systemic biology and molecular aberrations, the challenge facing many oncologists is staying recent and up-to-date with the future of cancer therapeutics. As such, TargetedOnc strives to provide the latest information on breaking news and updates on the burgeoning field. TargetedOnc focuses on the next stage of cancer development, focusing on cutting edge therapies and their biological targets. Content is organized by tumor type, news, and conference coverage.

About ACCC

The Association of Community Cancer Centers (ACCC) is the leading advocacy and education organization for the multidisciplinary cancer care team. More than 23,000 cancer care professionals from over 2,000 hospitals and practices nationwide are affiliated with ACCC. It is estimated that 65 percent of the nation's cancer patients are treated by a member of ACCC. Providing a national forum for addressing issues that affect community cancer programs, ACCC is recognized as the premier provider of resources for the entire oncology care team. Members include medical and radiation oncologists, surgeons, cancer program administrators and medical directors, senior hospital executives, practice managers, pharmacists, oncology nurses, radiation therapists, social workers, and cancer program data managers.

Contacts

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

Release Summary

OncLive® and Targeted Oncology™ Partner with the Association of Community Cancer Centers

Contacts

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com